ritivel is an AI-native regulatory platform designed for the life sciences sector. The company focuses on leveraging artificial intelligence to streamline regulatory processes and compliance in life sciences. Based in San Francisco, ritivel operates with a small team and aims to address complex regulatory challenges in the industry.
Facilitate regulatory submissions for life sciences companies; Automate compliance reporting for clinical trials; Manage regulatory data across multiple jurisdictions; Streamline interactions with regulatory agencies; Enhance data accuracy in regulatory documentation
ritivel offers an AI-native regulatory platform specifically designed for the life sciences sector. Their main product offerings include:
Clinical Study Reports (CSRs): This tool automates the drafting process, enabling users to generate CSRs in "minutes, not weeks." It features word-level traceability, ensuring that every statement can be traced back to its source document.
CTD Automation: This service facilitates literature searches and automatically drafts summaries for regulatory submissions, streamlining the submission process.
Regulatory Search: This feature provides instant access to answers from FDA and ICH guidelines, enhancing the efficiency of regulatory affairs professionals.
Key Features and Benefits:
These offerings are tailored for regulatory affairs professionals and compliance officers in pharmaceutical companies, addressing complex regulatory challenges in the industry.
Backed by Y Combinator W26; Serves clients in the life sciences sector; Focused on regulatory compliance challenges